Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia

References

• Yen S, Jaffe R. Reproductive endocrinology, 3rd edition. Philadelphia, PA: WB Saunders; 1991.
   Google Scholar
• Hamner MB, Arana GW. Hyperolactinaemia inantipsychotic treated patients: Guidelines for avoidance and management. CNS Drugs 1998;10:209–22.
   Web of Science ®Google Scholar
• Halbreich U, Kinon BJ, Gilmore JA, Kahn LS. Elevated prolactin levels in patients with schizophrenia: Mechanisms and related adverse effects. Psychoneuroendocrinology 2003;28:53–67.
   PubMed Web of Science ®Google Scholar
• Nordström AL, Farde L. Plasma prolactin and central D2 receptor occupancy in antipsychotic drug treated patients. J Clin Psychopharmacol 1998;18:305–10.
   PubMed Web of Science ®Google Scholar
• Kolakowska T, Williams AO, Ardern M, et al. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction. Br J Psychiatry 1985;146:229–39.
   PubMed Web of Science ®Google Scholar
• Melkersson K. Differences in prolactin elevation and related symptoms of atypical antipsychotics in schizophrenic patients. J Clin Psychiatry 2005;66:761–7.
   PubMed Web of Science ®Google Scholar
• Shrivastava A, Johnston M, Bureau Y, Shah N. Baseline serum prolactin in drug-naive, first-episode schizophrenia and outcome at five years: Is it a predictive factor?Innov Clin Neurosci 2012;9:17–21.
   PubMedGoogle Scholar
• Chatterjee SB. Dopamine related hormone levels in acute schizophrenia: A study of 84 patients. Indian J Psychiatry 1988;30:7–11.
   PubMedGoogle Scholar
• Kleinman JE, Weinberger DR, Rogol AD. Plasma prolactin concentration and psychopathology in chronic schizophrenia. Arch Gen Psychiatry 1982;39:655–65.
   PubMed Web of Science ®Google Scholar
• Kuruvilla K, Kuruvilla A, Kanagasbapathy AS. Serum prolactin levels in schizophrenia: Effects of neuroleptic medication preliminary study. Indian J Psychiatry 1986;28:237–41.
   PubMedGoogle Scholar
• Liberman JA, Kane JM, Woerker M. Prediction of relapse in schizophrenia. Clin Neuropharmacol 1990;131:434–5.
   Google Scholar
• Kirkpatrick B, Carpenter WT, Maeda K, et al. Plasma prolactin as a predictor of relapse in drug free schizophrenic outpatients. Biol Psychiatry 1992;32:1049–54.
   PubMed Web of Science ®Google Scholar
• Manschreck TC, Boshes RA. The CATIE schizophrenia trial: Results, impact, and controversy. Harv Rev Psychiatry 2007;15: 245–58.
   PubMed Web of Science ®Google Scholar
• Riecher-Rössler A, Rybakowski JK, Pflueger MO, Beyrau R, Kahn RS, Malik P, Fleischhacker WW; the EUFEST Study Group. Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis. Psychol Med 2013;17:1–12.
   Google Scholar
• Roelfsema F, Pijl H, Keenan DM, Veldhuis JD. Prolactin secretion in healthy adults is determined by gender, age and body mass index. PLoS One 2012;7(2):e31305.
   Web of Science ®Google Scholar
• Vermeulen A, Kaufman JM, Goemaere S, van Pelt I. Estradiol in elderly men. Aging Male 2002;5:98–102.
   PubMedGoogle Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Corapcioglu A, Aydemir O, Yildiz M. Structured Clinical Interview for DSM-IV (SCID-IV), Turkish Version (Turkish). Ankara: Hekimler Yayin Birligi; 1999.
   Google Scholar
• First MB, Spitzer RL, Gibbon M. Structured Clinical Interview for DSM IV Axis I Disorders (SCID), Clinician Version. Washington, DC: American Psychiatric Press; 1996.
   Google Scholar
• Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: College of Medicine, University of Iowa; 1984.
   Google Scholar
• Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: College of Medicine, University of Iowa; 1984.
   Google Scholar
• Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799–81.
   Web of Science ®Google Scholar
• Erkoç S, Arkonaç O, Ataklı C, Ozmen E.. Negatif semptomları değerlendirme ölçeğinin güvenirlirliği ve geçerliliği. Düşünen Adam 1991;4:16–19.
   Google Scholar
• Erkoç S, Arkonaç O, Ataklı C, Ozmen E. Pozitif semptomları değerlendirme ölçeğinin güvenirlirliği ve geçerliliği. Düşünen Adam 1991;4:20–4.
   Google Scholar
• Cookson JC, Silverstone T, Ross L. Plasma prolactin and growth hormone levels in manic patients treated with pimozide. Br J Psychiatry 1982;140:280–6.
   PubMed Web of Science ®Google Scholar
• Linkowski P, Vancauter E, L’Hermite-Baleriaux M, et al. The 24-hour profile of plasma prolactin in men with major endogenous depressive illness. Arch Gen Psychiatry 1989;46:813–19.
   PubMed Web of Science ®Google Scholar
• Song Y, Zhou D, Wang X. Increased serum cortisol and growth hormone levels in earthquake survivors with PTSD or subclinical PTSD. Psychoneuroendocrinology 2008;33:1155–9.
   PubMed Web of Science ®Google Scholar
• Shrivastava A, Tamhane M. Serum prolactin level and severity of psychopathology in patients of schizophrenia. Indian J Psychiatry 2000;42:48–51.
   PubMedGoogle Scholar
• Aston J, Rechsteiner E, Bull N, Borgwardt S, Gschwandtner U, Riecher-Rössler A. Hyperprolactinaemia in early psychosis—Not only due to antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2010 1;34:1342–4.
   Google Scholar
• McEwen BS, Alves SE, Bulloch K, Weiland NG. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 1997;48:8–15.
   PubMed Web of Science ®Google Scholar
• Arey BJ, Averill RL, Freeman ME. A sex-specific endogenous stimulatory rhythm regulating prolactin secretion. Endocrinology. 1989;124:119–23.
   PubMed Web of Science ®Google Scholar
• Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: Structure, function, and regulation of secretion. Physiol Rev 2000;80: 1523–631.
   PubMed Web of Science ®Google Scholar
• Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001;22:724–63.
   PubMed Web of Science ®Google Scholar
• Egli M, Leeners B, Kruger TH. Prolactin secretion patterns: Basic mechanisms and clinical implications for reproduction. Reproduction 2010;140:643–54.
   PubMed Web of Science ®Google Scholar
• Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B, et al. Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry 2005;58:417–23.
   PubMed Web of Science ®Google Scholar
• Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C, et al. Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology 2005;30:1923–31.
   PubMed Web of Science ®Google Scholar
• MacMaster FP, El-Sheikh R, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan M. Effect of antipsychotics on pituitary gland volume in treatment-naive first-episode schizophrenia: A pilot study. Schizophr Res 2007;92:207–10.
   PubMed Web of Science ®Google Scholar
• Mondelli V, Dazzan P, Gabilondo A, Tournikioti K, Walshe M, Marshall N, et al. Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology 2008;33:1004–12.
   PubMed Web of Science ®Google Scholar
• Mitchell AJ .The role of corticotropin releasing factor in depressive illness: A critical review. Neurosci Biobehav Rev 1999; 22:635–51.
   Web of Science ®Google Scholar
• Wahlestedt C, Merlo-Pich E, Koob GF, Yee F, Heilig M. Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides. Science 1993;259:528–31.
   PubMed Web of Science ®Google Scholar
• Kramer MS, Cutler N, Feghner J, Shrivastava R, Carman J, Sramek JJ, et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998;281: 1640–5.
   PubMed Web of Science ®Google Scholar
• Liebsch G, Wotjak CT, Landgraf R, Engelmann M. Septal vasopressin modulates anxiety-related behavior in rats. Neurosci Lett 1996;217:101–4.
   PubMed Web of Science ®Google Scholar
• Holsboer F, Barden N. Antidepressants and hypothalamicpituitary– adrenocortical regulation. Endocr Rev 1996;17:187–205.
   PubMed Web of Science ®Google Scholar
• Landgraf R, Wigger A, Holsboer F, Neumann ID. Hyper-reactive hypothalamo-pituitary–adrenocortical axis in rats bred for high anxiety related behavior. J Neuroendocrinol 1999;11: 405–7.
   PubMed Web of Science ®Google Scholar
• Neill JDEffects of “stress” on serum prolactin and luteinizing hormone levels during the estrous cycle of the rat. Endocrinology 1970;87:1192–7.
   PubMedGoogle Scholar
• Seggie JA, Brown GMStress response patterns of plasma corticosterone, prolactin, and growth hormone in the rat, following handling or exposure to novel environment. Can J Physiol Pharmacol 1975;53:629–37.
   PubMed Web of Science ®Google Scholar
• Fujikawa T, Soya H, Yoshizato H, Sakaguchi K, Doh-Ura K, Tanaka M, Nakasima KRestraint stress enhances the gene expression of prolactin receptor long form at the choroid plexus. Endocrinology 1995;136:5608–13.
   PubMed Web of Science ®Google Scholar
• Drago F, Continella G, Conforto G, Scapagnini U. Prolactin inhibits the development of stress-induced ulcers in the rat. Life Sci 1985;36:191–7.
   PubMed Web of Science ®Google Scholar
• Drago F, Pulvirenti L, Spadaro F, Pennisi G. Effects of TRH and prolactin in the behavioral despair (swim) model of depression in rats. Psychoneuroendocrinology 1990;15:349–56.
   PubMed Web of Science ®Google Scholar
• Torner L, Toschi N, Pohlinger A, Landgraf R, Neumann ID. Anxiolytic and anti-stress effects of brain prolactin: Improved efficacy of antisense targeting of the prolactin receptor by molecular modeling. J Neurosci 2001;21:3207–14.
   PubMed Web of Science ®Google Scholar
• Roncoroni, D. Relations between psychotic symptoms and serum prolactin levels. Pharmacopsychiatry 1989;22:71–5.
   PubMed Web of Science ®Google Scholar
• Harris DS, Wolkowitz OM, Reus VI. Psychoneuroendocrinology. In Sadock BJ, Sadack VA, editors. Comprehensive textbook of psychiatry, 8th edition. Philadelphia, PA: Williams & Wilkins; 2005. p. 126–37.
   Google Scholar
• Kok P, Roelfsema F, Frolich M, Meinders AE, Pijl H. Prolactin release is enhanced in proportion to excess visceral fat in obese women. J Clin Endocrinol Metab 2004;89:4445–9.
   PubMed Web of Science ®Google Scholar